News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Julie Gralow: 30 years since we founded Team Survivor Northwest
Julie Gralow/LinkedIn
Mar 4, 2025, 12:33

Julie Gralow: 30 years since we founded Team Survivor Northwest

Julie Gralow, Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO), shared a post on LinkedIn:

“Hard to believe that it’s been 30 years since we founded Team Survivor Northwest!

Empowering all women who have had a cancer diagnosis to THRIVE through fitness, education, and community.”

American Society of Clinical Oncology ASCO cancer fight against cancer Global fight against cancer Julie Gralow OncoDaily Oncology Survivor Northwest
Special Coverage
Blog
Mar 4, 2025, 12:33
Julie Gralow: 30 years since we founded Team Survivor Northwest
Blog
Mar 4, 2025, 12:30
Hatem Werdany: Honored to announce AstraZeneca Egypt's partnership with the Ministry of Health and Population - Egypt
Drugs
Mar 4, 2025, 12:28
Haydn Kissick: Cabozantinib as a neoadjuvant therapy for patients with clear cell RCC
Blog
Mar 4, 2025, 12:23
Efficiency implementation in the cancer care continuum - SPCC
Blog
Mar 4, 2025, 12:06
Nicholas Hornstein: Results for CRC liver metastasis from the COLLISION trial
Blog
Mar 4, 2025, 12:05
Sami (Papacek) Mansfield: What can you actually do to improve your gut microbiome?
Drugs
Mar 4, 2025, 11:58
Nihar Desai: 25 years of imatinib
Science
Mar 4, 2025, 11:54
Zeynep Irem Ozay: Challenges in the management of advanced prostate cancer
Blog
Mar 4, 2025, 11:50
Navneet Majhail: 80/20 effort to reduce REMS burden for Cell Therapy treatment centers
Blog
Mar 4, 2025, 11:35
Akshee Batra: Excited to present our poster at ESMOTAT25
Blog
Mar 4, 2025, 11:24
Manuel Arce von Herold about ESO Clinical Training Centres Fellowship Programme
Science
Mar 4, 2025, 11:22
Heidi Ko: Our latest mini-review on HER2 as a tumor-agnostic biomarker